TipRanks
Go Ultimate55% OFF

Contineum Therapeutics, Inc. Class A (CTNM) Cash flow

Contineum Therapeutics, Inc. Class A Cash Flow

CTNM's free cash flow for Q2 2026 was $-11.51M. For the 2026 fiscal year, CTNM's free cash flow was decreased by $-6.00K and operating cash flow was $-11.50M. See a summary of the company’s cash flow.

Cash Flow
Cash FlowDec 25Dec 24Dec 23Dec 22Dec 21
$ -55.31M$ -32.84M$ 19.35M$ -20.12M$ -26.27M
$ -3.71M$ -69.74M$ -65.57M$ 22.30M$ -64.97M
$ 112.69M$ 109.00M$ 56.18M$ -1.24M$ 79.84M
$ 75.60M$ 21.94M$ 15.53M$ 5.57M$ 4.63M
$ -55.54M$ -33.36M$ 18.93M$ -20.24M$ -26.43M

Currency in USD

Contineum Therapeutics, Inc. Class A Cash Flow

-100M-50M050M100M150M20212022202320242025OperatingInvestingFinancing